Medtronic plc (0Y6X.L)
USD 83.71
(1.22%)
USD 83.71
(1.22%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 23.87 Billion USD | -1.69% |
| 2022 | 24.28 Billion USD | 19.55% |
| 2021 | 20.31 Billion USD | -22.8% |
| 2020 | 26.31 Billion USD | 19.75% |
| 2019 | 21.97 Billion USD | -10.21% |
| 2018 | 24.47 Billion USD | 3.37% |
| 2017 | 23.67 Billion USD | -8.57% |
| 2016 | 25.89 Billion USD | -13.91% |
| 2015 | 30.08 Billion USD | -11.06% |
| 2014 | 33.82 Billion USD | 227.55% |
| 2013 | 10.32 Billion USD | 5.81% |
| 2012 | 9.75 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 26.26 Billion USD | 9.98% |
| 2023 Q4 | 23.87 Billion USD | -0.91% |
| 2023 FY | 23.87 Billion USD | -1.69% |
| 2023 Q1 | 24.4 Billion USD | 0.49% |
| 2023 Q3 | 24.09 Billion USD | 1.74% |
| 2023 Q2 | 23.68 Billion USD | -2.95% |
| 2022 Q3 | 22.15 Billion USD | 7.04% |
| 2022 Q1 | 17.42 Billion USD | -14.24% |
| 2022 FY | 24.28 Billion USD | 19.55% |
| 2022 Q4 | 24.28 Billion USD | 9.62% |
| 2022 Q2 | 20.69 Billion USD | 18.8% |
| 2021 Q1 | 25.89 Billion USD | -1.59% |
| 2021 Q3 | 24.23 Billion USD | -5.15% |
| 2021 Q4 | 20.31 Billion USD | -16.16% |
| 2021 Q2 | 25.54 Billion USD | -1.35% |
| 2021 FY | 20.31 Billion USD | -22.8% |
| 2020 Q1 | 22.86 Billion USD | 0.32% |
| 2020 FY | 26.31 Billion USD | 19.75% |
| 2020 Q2 | 25.96 Billion USD | 13.56% |
| 2020 Q3 | 26.5 Billion USD | 2.06% |
| 2020 Q4 | 26.31 Billion USD | -0.7% |
| 2019 FY | 21.97 Billion USD | -10.21% |
| 2019 Q3 | 25.58 Billion USD | -0.01% |
| 2019 Q2 | 25.58 Billion USD | -0.05% |
| 2019 Q1 | 25.59 Billion USD | 4.55% |
| 2019 Q4 | 22.79 Billion USD | -10.9% |
| 2018 Q3 | 23.68 Billion USD | -0.03% |
| 2018 Q2 | 23.69 Billion USD | -0.02% |
| 2018 Q1 | 23.69 Billion USD | -0.1% |
| 2018 FY | 24.47 Billion USD | 3.37% |
| 2018 Q4 | 24.48 Billion USD | 3.39% |
| 2017 Q1 | 25.96 Billion USD | 0.12% |
| 2017 Q3 | 25.93 Billion USD | -0.07% |
| 2017 Q4 | 23.71 Billion USD | -8.53% |
| 2017 FY | 23.67 Billion USD | -8.57% |
| 2017 Q2 | 25.94 Billion USD | -0.05% |
| 2016 Q3 | 25.96 Billion USD | -10.71% |
| 2016 FY | 25.89 Billion USD | -13.91% |
| 2016 Q2 | 29.07 Billion USD | -3.74% |
| 2016 Q4 | 25.93 Billion USD | -0.11% |
| 2016 Q1 | 30.2 Billion USD | 0.15% |
| 2015 FY | 30.08 Billion USD | -11.06% |
| 2015 Q4 | 30.16 Billion USD | -10.57% |
| 2015 Q3 | 33.72 Billion USD | -0.12% |
| 2015 Q2 | 33.76 Billion USD | 0.05% |
| 2015 Q1 | 33.75 Billion USD | -0.22% |
| 2014 FY | 33.82 Billion USD | 227.55% |
| 2014 Q3 | 26.71 Billion USD | 174.33% |
| 2014 Q2 | 9.73 Billion USD | -5.67% |
| 2014 Q1 | 10.32 Billion USD | -0.03% |
| 2014 Q4 | 33.82 Billion USD | 26.61% |
| 2013 Q1 | 9.65 Billion USD | -1.1% |
| 2013 Q3 | 9.61 Billion USD | -0.27% |
| 2013 FY | 10.32 Billion USD | 5.81% |
| 2013 Q4 | 10.32 Billion USD | 7.39% |
| 2013 Q2 | 9.64 Billion USD | -0.11% |
| 2012 Q3 | 7.23 Billion USD | 0.0% |
| 2012 FY | 9.75 Billion USD | 0.0% |
| 2012 Q4 | 9.75 Billion USD | 34.92% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -1165200.146% |
| Accuray Incorporated | 164.4 Million USD | -14423.723% |
| Align Technology, Inc. | 96.96 Million USD | -24523.587% |
| Elevance Health Inc. | 23.24 Billion USD | -2.714% |
| AxoGen, Inc. | 46.6 Million USD | -51134.899% |
| Boston Scientific Corporation | 8.56 Billion USD | -178.742% |
| CVS Health Corporation | 74.67 Billion USD | 68.024% |
| Cardinal Health, Inc. | 4.58 Billion USD | -420.991% |
| Centene Corporation | 17.69 Billion USD | -34.906% |
| DaVita Inc. | 8.05 Billion USD | -196.563% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 34.812% |
| Hologic, Inc. | 2.49 Billion USD | -856.189% |
| Humana Inc. | 10.21 Billion USD | -133.79% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -3733.304% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -488.872% |
| Masimo Corporation | 871.7 Million USD | -2639.13% |
| McKesson Corporation | 5.45 Billion USD | -338.03% |
| Patterson Companies, Inc. | 328.91 Million USD | -7159.411% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -441.429% |
| ResMed Inc. | 697.31 Million USD | -3324.144% |
| Henry Schein, Inc. | 1.93 Billion USD | -1135.23% |
| Teladoc Health, Inc. | 1.58 Billion USD | -1409.745% |
| Universal Health Services, Inc. | 4.71 Billion USD | -406.283% |
| Veeva Systems Inc. | 46.44 Million USD | -51313.622% |
| Baxter International Inc. | 11.06 Billion USD | -115.808% |
| Becton, Dickinson and Company | 14.73 Billion USD | -62.01% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 29182.826% |
| Danaher Corporation | 17.66 Billion USD | -35.196% |
| Stryker Corporation | 10.9 Billion USD | -119.035% |